Muscle regeneration, inflammation, and connective tissue expansion in canine inflammatory myopathy

Muscle and Nerve

Volumn 31, Issue 2, 2005, Pages 192-198

  Salvadori, Claudia ^a   Peters, Iain R ^b   Day, Michael J ^b   Engvall, Eva ^c   Shelton, G Diane ^d  

^a Faculty of Veterinary Medicine   (Italy)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c BURNHAM INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemokines; Cytokines; Fibrosis; Muscle; Myositis

Indexed keywords

CHEMOKINE; COLLAGEN TYPE 4; CYTOKINE; EOTAXIN; FIBRILLIN; HEMATOXYLIN; MESSENGER RNA; MYOSIN HEAVY CHAIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; EOSINOPHIL; FIBROSIS; IMMUNODETECTION; MUSCLE BIOPSY; MUSCLE REGENERATION; MYOSITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE EXPANSION; UPREGULATION;

ANIMALS; CONNECTIVE TISSUE; DOG DISEASES; DOGS; MUSCLE, SKELETAL; MYOSITIS; POLYMYOSITIS; REGENERATION;

EID: 13244289785     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20252     Document Type: Article

References (50)

1. Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pita O, Puddu P. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr Drug Targets Inflamm Allergy 2003;2:81-94.
2. Arnold H, Winter B. Muscle differentiation: more complexity to the network of myogenic regulators. Curr Opin Genet Dev 1998;8:539-544.
3. Bergman R, Inzana KD, Monroe WE, Shell LG, Liu LA, Engvall E, Shelton GD. Dystrophin-deficient muscular dystrophy in a Labrador retriever. J Am Anim Hosp Assoc 2002;38:255-261.
4. Bernasconi P, Di Balsi C, Mora M, Morandi L, Galbiati S, Confalonieri P, Cornelio F, Mantegazza R. Transforming growth factor-β1 and fibrosis in congenital muscular dystrophies. Neuromuscul Disord 1998;9:28-33.
5. Bernasconi P, Torchiani E, Gonfalonieri P, Brugnoni R, Barresi R, Mora M, Cornelio F, Moranti L, Mantegazza R. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest 1995;96:1137-1144.
6. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest 1992;90:1-7.
7. Bornemann A, Schmalbruch H. Desmin and vimentin in regenerating muscles. Muscle Nerve 1992;15:14-20.
8. Cai B, Spencer MJ, Nakamura G, Tseng-Ong L, Tidball JG. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T-cell effectors. Am J Pathol 2000;156:1789-1796.
9. Carpenter S, Karpati G. Major pathological reactions and their consequences for skeletal muscle. In: Pathology of skeletal muscle. Oxford: University Press; 2001. p 85.
10. Confalonieri P, Bernasconi P, Cornelio F, Montegazza R. Transforming growth factor β1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrates. J Neuropathol Exp Neurol 1997;56:479-484.
11. Confalonieri P, Bernasconi P, Megna P, Galbiati S, Cornelio F, Mantegazza R. Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies. J Neuropathol Exp Neurol 2000;59:164-169.
12. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:1762-1763.
13. Dalakas MC. From canine to man: on antibodies, macrophages, and dendritic cells in inflammatory myopathies. Muscle Nerve 2004;29:753-755.
14. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Exp Med 1996;183:2349-2354.
15. DeRossi M, Bernasconi P, Baggi F, de Waal Malefyt R, Mantegazza R. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int Immunol 2000;12:1329-1335.
16. Ecob-Prince M, Hill M, Brown W. Immunocytochemical demonstration of myosin heavy chain expression in human muscle. J Neurol Sci 1989;91:71-78.
17. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984;16:209-2I5.
18. Engel AG, Hohlfeld R. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill; 2004. p 1321-1388.
19. Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndromes. In: Engel AG, Franzini-Armstrong, editors. Myology. New York: McGraw-Hill; 1994. p 1335-1383.
20. Evans J, Levesque D, Shelton GD. Canine inflammatory myopathies: a clinicopathologic review of 200 cases. J Vet Intern Med 2004;18:679-691.
21. Forssmann U, Uguccioni M, Loetscher P, Dahinden CA, Langen H, Thelen M, Baggiolini M. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 1997;185:2171-2176.
22. Helliwell TR, Nguyen TM, Morrist GE, Davies KE. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibers in dystrophies and inflammatory myopathies. Neuromuscul Disord 1992;2:177-184.
23. Hessle H, Engvall E. Type VI collagen. Studies on its localization, structure, and biosynthetic form with monoclonal antibodies. J Biol Chem 1984;259:3955-3961.
24. Huaux F, Liu T, McGarry B, Ullenbruch M, Xing Z, Phan SH. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis. J Immunol 2003;171:5470-5481.
25. Jin Y, Murakami N, Saito Y, Goto Y, Koishi K, Nonaka I. Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration. Acta Neuropathol (Berl) 2000;99:619-627.
26. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-887.
27. Kitaura M, Suzuki N, Imai T, Takagi S, Suzuki R, Nakajima T, Hirai K, Nomiyama H, Yoshie O. Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J Biol Chem 1999;274:27975-27980.
28. Knudsen KA, Horwitz AF. The plasma membrane of the muscle fiber: adhesion molecules. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill; 1994. p 223-241.
29. Kornegay JN, Gorgacz EJ, Dawe DL, Bowen JM, White NA, DeBuyssher EV. Polymyositis in dogs. J Am Vet Med Assoc 1980;176:431-438.
30. Kumar V, Cotran RS, Robbins SL. Acute and chronic inflammation. In: Kumar V, Cotran RS, Robbins SL, editors. Basic pathology, 5th ed. Philadelphia: WB Saunders; 1992, p 25-46.
31. Lampinen M, Carlson M, Hakansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory diseases. Allergy 2004;59:793-805.
32. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J, Huard J. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 2004;164:1007-1019.
33. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 1999;190:267-280.
34. Parham DM, Dias P, Bertorini T, von Wronski MA, Horner L, Houghton P. Immunohistochemical analysis of the distribution of MyoD1 in muscle biopsies of primary myopathies and neurogenic atrophy. Acta Neuropathol (Berl) 1994;87:605-611.
35. Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, Nardelli B, Pippalla V, Gentz S, Thotakura R, Parmelee D, Gentz R, Garotta G. Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J Exp Med 1997;185:1163-1172.
36. Peters IR, Helps CR, Calvert EL, Hall EJ, Day MJ. Identification of four allelic variants of the dog IGHA gene. Immunogenetics 2004;56:254-260.
37. Peters IR, Helps CR, Hall EJ, Day MJ. Real-time RT-PCR: considerations for efficient and sensitive assay design. J Immunol Methods 2004;286:203-217.
38. Phipps S, Ying S, Wangoo A, Ong YE, Levi-Schaffer F, Kay AB. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 2002;169:4604-4612.
39. Pickering MC, Walport MJ. Eosinophilic myopathie syndromes. Curr Opin Rheumatol 1998;10:504-510.
40. Podell M. Inflammatory myopathies. Vet Clin N Am Small Anim Pract 2002;32:147-167.
41. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, Newman W, Gerard C, Mackay CR. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996;183:2437-2448.
42. Pumarola M, Moore PF, Shelton GD. Canine inflammatory myopathy: analysis of cellular infiltrates. Muscle Nerve 2004;29:782-789.
43. Sabourin LA, Girgis-Gabardo A, Seale P, Asakura A, Rudnicky MA. Reduced differentiation potential of primary MyoD-/-myogenic cells derived from adult skeletal muscle. J Cell Biol 1999;144:631-643.
44. Saito A, Okazaki H, Sugawara I, Yamamoto K, Takizawa H. Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol 2003;132:168-176.
45. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350 kd glycoprotein is a component of extracellular microfibrils. J Cell Biol 1986;103:2499-2509.
46. Sarnat HB. Vimentin and desmin in maturing skeletal muscle and developmental myopathies. Neurology 1992;42:1616-1624.
47. Shelton GD, Cardinet GH III, Bandman E. Canine masticatory muscle disorders: a study of 29 cases. Muscle Nerve 1987;10:753-766.
48. Shinkai A, Yoshisue H, Koike M, Shoji E, Nakagawa S, Saito A, Takeda T, Imabeppu S, Kato Y, Hanai N, Anazawa H, Kuga T, Nishi T. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 1999;163:1602-1610.
49. Winter A, Bornemann A. NCAM, vimentin and neonatal myosin heavy chain expression in human muscle diseases. Neuropathol Appl Neurobiol 1999;25:417-424.
50. Young C, Lin MY, Wang PJ, Shen YZ. Immunocytochemical studies on desmin and vimentin in neuromuscular disorders. J Formosa Med Assoc 1994;93:829-835.